Global Biosimilar Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
- MAI4687769
- 124 Pages
- December 2021
- Pharmaceuticals
Based on the Biosimilar market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Biosimilar market covered in Chapter 5:
Hospira (Pfizer)
Changchun High Tech
Teva Pharmaceutical
Sun pharma
MYLAN
Gelgen Biopharma
CP Guojian Pharmacy
3sbio
Biotech Pharma
SANDOZ (NOVARTIS)
In Chapter 6, on the basis of types, the Biosimilar market from 2015 to 2025 is primarily split into:
Predictive Testing
Carrier Testing
Prenatal And Newborn Testing
Diagnostic Testing
Pharmacogenomic Testing
In Chapter 7, on the basis of applications, the Biosimilar market from 2015 to 2025 covers:
Infectious Disease
Blood Screening
Genetic Testing
Oncology Testing
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Biosimilar Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Hospira (Pfizer)
5.1.1 Hospira (Pfizer) Company Profile
5.1.2 Hospira (Pfizer) Business Overview
5.1.3 Hospira (Pfizer) Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Hospira (Pfizer) Biosimilar Products Introduction
5.2 Changchun High Tech
5.2.1 Changchun High Tech Company Profile
5.2.2 Changchun High Tech Business Overview
5.2.3 Changchun High Tech Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Changchun High Tech Biosimilar Products Introduction
5.3 Teva Pharmaceutical
5.3.1 Teva Pharmaceutical Company Profile
5.3.2 Teva Pharmaceutical Business Overview
5.3.3 Teva Pharmaceutical Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Teva Pharmaceutical Biosimilar Products Introduction
5.4 Sun pharma
5.4.1 Sun pharma Company Profile
5.4.2 Sun pharma Business Overview
5.4.3 Sun pharma Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Sun pharma Biosimilar Products Introduction
5.5 MYLAN
5.5.1 MYLAN Company Profile
5.5.2 MYLAN Business Overview
5.5.3 MYLAN Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 MYLAN Biosimilar Products Introduction
5.6 Gelgen Biopharma
5.6.1 Gelgen Biopharma Company Profile
5.6.2 Gelgen Biopharma Business Overview
5.6.3 Gelgen Biopharma Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Gelgen Biopharma Biosimilar Products Introduction
5.7 CP Guojian Pharmacy
5.7.1 CP Guojian Pharmacy Company Profile
5.7.2 CP Guojian Pharmacy Business Overview
5.7.3 CP Guojian Pharmacy Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 CP Guojian Pharmacy Biosimilar Products Introduction
5.8 3sbio
5.8.1 3sbio Company Profile
5.8.2 3sbio Business Overview
5.8.3 3sbio Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 3sbio Biosimilar Products Introduction
5.9 Biotech Pharma
5.9.1 Biotech Pharma Company Profile
5.9.2 Biotech Pharma Business Overview
5.9.3 Biotech Pharma Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Biotech Pharma Biosimilar Products Introduction
5.10 SANDOZ (NOVARTIS)
5.10.1 SANDOZ (NOVARTIS) Company Profile
5.10.2 SANDOZ (NOVARTIS) Business Overview
5.10.3 SANDOZ (NOVARTIS) Biosimilar Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 SANDOZ (NOVARTIS) Biosimilar Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Biosimilar Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Biosimilar Sales and Market Share by Types (2015-2020)
6.1.2 Global Biosimilar Revenue and Market Share by Types (2015-2020)
6.1.3 Global Biosimilar Price by Types (2015-2020)
6.2 Global Biosimilar Market Forecast by Types (2020-2025)
6.2.1 Global Biosimilar Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Biosimilar Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Biosimilar Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Biosimilar Sales, Price and Growth Rate of Predictive Testing
6.3.2 Global Biosimilar Sales, Price and Growth Rate of Carrier Testing
6.3.3 Global Biosimilar Sales, Price and Growth Rate of Prenatal And Newborn Testing
6.3.4 Global Biosimilar Sales, Price and Growth Rate of Diagnostic Testing
6.3.5 Global Biosimilar Sales, Price and Growth Rate of Pharmacogenomic Testing
6.4 Global Biosimilar Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Predictive Testing Market Revenue and Sales Forecast (2020-2025)
6.4.2 Carrier Testing Market Revenue and Sales Forecast (2020-2025)
6.4.3 Prenatal And Newborn Testing Market Revenue and Sales Forecast (2020-2025)
6.4.4 Diagnostic Testing Market Revenue and Sales Forecast (2020-2025)
6.4.5 Pharmacogenomic Testing Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Biosimilar Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Biosimilar Sales and Market Share by Applications (2015-2020)
7.1.2 Global Biosimilar Revenue and Market Share by Applications (2015-2020)
7.2 Global Biosimilar Market Forecast by Applications (2020-2025)
7.2.1 Global Biosimilar Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Biosimilar Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Biosimilar Revenue, Sales and Growth Rate of Infectious Disease (2015-2020)
7.3.2 Global Biosimilar Revenue, Sales and Growth Rate of Blood Screening (2015-2020)
7.3.3 Global Biosimilar Revenue, Sales and Growth Rate of Genetic Testing (2015-2020)
7.3.4 Global Biosimilar Revenue, Sales and Growth Rate of Oncology Testing (2015-2020)
7.4 Global Biosimilar Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Infectious Disease Market Revenue and Sales Forecast (2020-2025)
7.4.2 Blood Screening Market Revenue and Sales Forecast (2020-2025)
7.4.3 Genetic Testing Market Revenue and Sales Forecast (2020-2025)
7.4.4 Oncology Testing Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Biosimilar Sales by Regions (2015-2020)
8.2 Global Biosimilar Market Revenue by Regions (2015-2020)
8.3 Global Biosimilar Market Forecast by Regions (2020-2025)
9 North America Biosimilar Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Biosimilar Market Sales and Growth Rate (2015-2020)
9.3 North America Biosimilar Market Revenue and Growth Rate (2015-2020)
9.4 North America Biosimilar Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Biosimilar Market Analysis by Country
9.6.1 U.S. Biosimilar Sales and Growth Rate
9.6.2 Canada Biosimilar Sales and Growth Rate
9.6.3 Mexico Biosimilar Sales and Growth Rate
10 Europe Biosimilar Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Biosimilar Market Sales and Growth Rate (2015-2020)
10.3 Europe Biosimilar Market Revenue and Growth Rate (2015-2020)
10.4 Europe Biosimilar Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Biosimilar Market Analysis by Country
10.6.1 Germany Biosimilar Sales and Growth Rate
10.6.2 United Kingdom Biosimilar Sales and Growth Rate
10.6.3 France Biosimilar Sales and Growth Rate
10.6.4 Italy Biosimilar Sales and Growth Rate
10.6.5 Spain Biosimilar Sales and Growth Rate
10.6.6 Russia Biosimilar Sales and Growth Rate
11 Asia-Pacific Biosimilar Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Biosimilar Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Biosimilar Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Biosimilar Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Biosimilar Market Analysis by Country
11.6.1 China Biosimilar Sales and Growth Rate
11.6.2 Japan Biosimilar Sales and Growth Rate
11.6.3 South Korea Biosimilar Sales and Growth Rate
11.6.4 Australia Biosimilar Sales and Growth Rate
11.6.5 India Biosimilar Sales and Growth Rate
12 South America Biosimilar Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Biosimilar Market Sales and Growth Rate (2015-2020)
12.3 South America Biosimilar Market Revenue and Growth Rate (2015-2020)
12.4 South America Biosimilar Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Biosimilar Market Analysis by Country
12.6.1 Brazil Biosimilar Sales and Growth Rate
12.6.2 Argentina Biosimilar Sales and Growth Rate
12.6.3 Columbia Biosimilar Sales and Growth Rate
13 Middle East and Africa Biosimilar Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Biosimilar Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Biosimilar Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Biosimilar Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Biosimilar Market Analysis by Country
13.6.1 UAE Biosimilar Sales and Growth Rate
13.6.2 Egypt Biosimilar Sales and Growth Rate
13.6.3 South Africa Biosimilar Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Biosimilar Market Size and Growth Rate 2015-2025
Table Biosimilar Key Market Segments
Figure Global Biosimilar Market Revenue ($) Segment by Type from 2015-2020
Figure Global Biosimilar Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Biosimilar
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Hospira (Pfizer) Company Profile
Table Hospira (Pfizer) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hospira (Pfizer) Production and Growth Rate
Figure Hospira (Pfizer) Market Revenue ($) Market Share 2015-2020
Table Changchun High Tech Company Profile
Table Changchun High Tech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Changchun High Tech Production and Growth Rate
Figure Changchun High Tech Market Revenue ($) Market Share 2015-2020
Table Teva Pharmaceutical Company Profile
Table Teva Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Pharmaceutical Production and Growth Rate
Figure Teva Pharmaceutical Market Revenue ($) Market Share 2015-2020
Table Sun pharma Company Profile
Table Sun pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sun pharma Production and Growth Rate
Figure Sun pharma Market Revenue ($) Market Share 2015-2020
Table MYLAN Company Profile
Table MYLAN Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure MYLAN Production and Growth Rate
Figure MYLAN Market Revenue ($) Market Share 2015-2020
Table Gelgen Biopharma Company Profile
Table Gelgen Biopharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Gelgen Biopharma Production and Growth Rate
Figure Gelgen Biopharma Market Revenue ($) Market Share 2015-2020
Table CP Guojian Pharmacy Company Profile
Table CP Guojian Pharmacy Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CP Guojian Pharmacy Production and Growth Rate
Figure CP Guojian Pharmacy Market Revenue ($) Market Share 2015-2020
Table 3sbio Company Profile
Table 3sbio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure 3sbio Production and Growth Rate
Figure 3sbio Market Revenue ($) Market Share 2015-2020
Table Biotech Pharma Company Profile
Table Biotech Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biotech Pharma Production and Growth Rate
Figure Biotech Pharma Market Revenue ($) Market Share 2015-2020
Table SANDOZ (NOVARTIS) Company Profile
Table SANDOZ (NOVARTIS) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure SANDOZ (NOVARTIS) Production and Growth Rate
Figure SANDOZ (NOVARTIS) Market Revenue ($) Market Share 2015-2020
Table Global Biosimilar Sales by Types (2015-2020)
Table Global Biosimilar Sales Share by Types (2015-2020)
Table Global Biosimilar Revenue ($) by Types (2015-2020)
Table Global Biosimilar Revenue Share by Types (2015-2020)
Table Global Biosimilar Price ($) by Types (2015-2020)
Table Global Biosimilar Market Forecast Sales by Types (2020-2025)
Table Global Biosimilar Market Forecast Sales Share by Types (2020-2025)
Table Global Biosimilar Market Forecast Revenue ($) by Types (2020-2025)
Table Global Biosimilar Market Forecast Revenue Share by Types (2020-2025)
Figure Global Predictive Testing Sales and Growth Rate (2015-2020)
Figure Global Predictive Testing Price (2015-2020)
Figure Global Carrier Testing Sales and Growth Rate (2015-2020)
Figure Global Carrier Testing Price (2015-2020)
Figure Global Prenatal And Newborn Testing Sales and Growth Rate (2015-2020)
Figure Global Prenatal And Newborn Testing Price (2015-2020)
Figure Global Diagnostic Testing Sales and Growth Rate (2015-2020)
Figure Global Diagnostic Testing Price (2015-2020)
Figure Global Pharmacogenomic Testing Sales and Growth Rate (2015-2020)
Figure Global Pharmacogenomic Testing Price (2015-2020)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Predictive Testing (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Predictive Testing (2020-2025)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Carrier Testing (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Carrier Testing (2020-2025)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Prenatal And Newborn Testing (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Prenatal And Newborn Testing (2020-2025)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Diagnostic Testing (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Diagnostic Testing (2020-2025)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Pharmacogenomic Testing (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Pharmacogenomic Testing (2020-2025)
Table Global Biosimilar Sales by Applications (2015-2020)
Table Global Biosimilar Sales Share by Applications (2015-2020)
Table Global Biosimilar Revenue ($) by Applications (2015-2020)
Table Global Biosimilar Revenue Share by Applications (2015-2020)
Table Global Biosimilar Market Forecast Sales by Applications (2020-2025)
Table Global Biosimilar Market Forecast Sales Share by Applications (2020-2025)
Table Global Biosimilar Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Biosimilar Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Infectious Disease Sales and Growth Rate (2015-2020)
Figure Global Infectious Disease Price (2015-2020)
Figure Global Blood Screening Sales and Growth Rate (2015-2020)
Figure Global Blood Screening Price (2015-2020)
Figure Global Genetic Testing Sales and Growth Rate (2015-2020)
Figure Global Genetic Testing Price (2015-2020)
Figure Global Oncology Testing Sales and Growth Rate (2015-2020)
Figure Global Oncology Testing Price (2015-2020)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Infectious Disease (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Infectious Disease (2020-2025)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Blood Screening (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Blood Screening (2020-2025)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Genetic Testing (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Genetic Testing (2020-2025)
Figure Global Biosimilar Market Revenue ($) and Growth Rate Forecast of Oncology Testing (2020-2025)
Figure Global Biosimilar Sales and Growth Rate Forecast of Oncology Testing (2020-2025)
Figure Global Biosimilar Sales and Growth Rate (2015-2020)
Table Global Biosimilar Sales by Regions (2015-2020)
Table Global Biosimilar Sales Market Share by Regions (2015-2020)
Figure Global Biosimilar Sales Market Share by Regions in 2019
Figure Global Biosimilar Revenue and Growth Rate (2015-2020)
Table Global Biosimilar Revenue by Regions (2015-2020)
Table Global Biosimilar Revenue Market Share by Regions (2015-2020)
Figure Global Biosimilar Revenue Market Share by Regions in 2019
Table Global Biosimilar Market Forecast Sales by Regions (2020-2025)
Table Global Biosimilar Market Forecast Sales Share by Regions (2020-2025)
Table Global Biosimilar Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Biosimilar Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Biosimilar Market Sales and Growth Rate (2015-2020)
Figure North America Biosimilar Market Revenue and Growth Rate (2015-2020)
Figure North America Biosimilar Market Forecast Sales (2020-2025)
Figure North America Biosimilar Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Canada Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Mexico Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Europe Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Europe Biosimilar Market Revenue and Growth Rate (2015-2020)
Figure Europe Biosimilar Market Forecast Sales (2020-2025)
Figure Europe Biosimilar Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Biosimilar Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Biosimilar Market Sales and Growth Rate (2015-2020)
Figure France Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Italy Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Spain Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Russia Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilar Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilar Market Forecast Sales (2020-2025)
Figure Asia-Pacific Biosimilar Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Japan Biosimilar Market Sales and Growth Rate (2015-2020)
Figure South Korea Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Australia Biosimilar Market Sales and Growth Rate (2015-2020)
Figure India Biosimilar Market Sales and Growth Rate (2015-2020)
Figure South America Biosimilar Market Sales and Growth Rate (2015-2020)
Figure South America Biosimilar Market Revenue and Growth Rate (2015-2020)
Figure South America Biosimilar Market Forecast Sales (2020-2025)
Figure South America Biosimilar Market Forecast Revenue ($) (2020-2025)
Figure Brazil Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Argentina Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Columbia Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilar Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilar Market Forecast Sales (2020-2025)
Figure Middle East and Africa Biosimilar Market Forecast Revenue ($) (2020-2025)
Figure UAE Biosimilar Market Sales and Growth Rate (2015-2020)
Figure Egypt Biosimilar Market Sales and Growth Rate (2015-2020)
Figure South Africa Biosimilar Market Sales and Growth Rate (2015-2020)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
